Yayınlar & Eserler

Yayın Ağı
Makaleler 70
Tümü (70)
SCI-E, SSCI, AHCI (52)
SCI-E, SSCI, AHCI, ESCI (55)
ESCI (3)
Scopus (65)
TRDizin (10)
Diğer Yayınlar (5)

1. The effects of UGT1A4 and ABCB1 polymorphisms on clozapine and Ndesmethyl clozapine plasma levels in Turkish schizophrenia patients

Ozdemir F., Oz M. D., Tok K. C., Dural E., Kır Y., Gumustas M., et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY , cilt.495, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. The role of tissue persistent organic pollutants and genetic polymorphisms in patients with benign and malignant kidney tumors

KOCAGÖZ R., Onat l., Oz M., Turna B., Kumbaraci B. S., ORMAN M. N., et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY , cilt.110, 2024 (SCI-Expanded) identifier identifier identifier

3. Blood and tissue levels of persistent organic pollutants and genetic susceptibility in patients with breast cancer

Onat İ., Kocagöz R., DEMİRBÜGEN ÖZ M., Yeniay L., Tiftikçioğlu Y. Ö., Zekioğlu O., et al.
Environmental Toxicology and Pharmacology , cilt.108, 2024 (SCI-Expanded) identifier identifier

4. The relationship between lymphocyte DNA damage, coronary artery disease, and blood trace elements

Erdogu I., DURAL E., ALTUNDAĞ H., OYMAK T., SÜZEN H. S.
MUTAGENESIS , sa.1, ss.43-55, 2024 (SCI-Expanded) identifier identifier

5. Relationship between circadian and social rhythm regulation, chronotype, COMT, CLOCK, GSK3-ß gene polymorphisms and valproate response in remitted bipolar subjects

ULUSOY ALTINOKLU M., BASKAK B., TOK K. C., SÜZEN H. S., ÇAKMAK I. B.
Neuroscience Applied , cilt.2024, sa.3, ss.253, 2024 (Hakemli Dergi) Creative Commons License Sürdürülebilir Kalkınma

6. Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics.

Hart X. M., Gründer G., Ansermot N., Conca A., Corruble E., Crettol S., et al.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry , cilt.25, sa.9, ss.451-536, 2024 (SCI-Expanded) identifier identifier identifier

7. Evaluation of distal tibial epiphysis and calcaneal epiphysis according to the Vieth method in 3.0 T magnetic resonance images: a pilot study

Gurses M. S., Has B., Altinsoy H. B., SÜZEN H. S.
INTERNATIONAL JOURNAL OF LEGAL MEDICINE , cilt.137, sa.4, ss.1181-1191, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

8. Association between superoxide dismutase 2, glutathione peroxidase 1, xeroderma pigmentosum group d gene variations, and head and neck squamous cell cancer susceptibility

Kose G., Oz M., CÖMERT E., SÜZEN H. S.
ARCHIVES OF BIOLOGICAL SCIENCES , cilt.74, sa.2, ss.181-189, 2022 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

9. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants.

Eap C. B., Grunder G., Baumann P., Ansermot N., Conca A., Corruble E., et al.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry , cilt.22, sa.8, ss.561-628, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

10. The Influence of Genetic Variations and Drug Interactions Based on Metabolism of Antidepressants and Anticonvulsants

DEMİRBÜGEN ÖZ M., Ozdemir F., SÜZEN H. S.
Current drug metabolism , cilt.22, sa.8, ss.596-627, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

11. A Novel Genotyping Method for Detection of Muscarinic Receptor M1 Gene rs2067477 Polymorphism and Its Genotype/Allele Frequencies in a Turkish Population

ÖZDEMİR F., KIR Y., TOK K. C., BASKAK B., SÜZEN H. S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.17, sa.6, ss.653-658, 2020 (ESCI)

12. The Effect of Enantiomer Elution Order on the Determination of Minor Enantiomeric Impurity in Ketoprofen and Enantiomeric Purity Evaluation of Commercially Available Dexketoprofen Formulations

Tok K. C., Gümüştaş M., Jibuti G., Süzen H. S., Özkan S. A., Chankvetadze B.
MOLECULES , cilt.25, sa.24, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

13. A Novel Genotyping Method for Detection of the Muscarinic Receptor M1 Gene rs2067477 Polymorphism and Its Genotype/Allele Frequencies in a Turkish Population

Ozdemir F., Kir Y., TOK K. C., BASKAK B., SÜZEN H. S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.17, sa.6, ss.653-658, 2020 (ESCI, Scopus, TRDizin) identifier identifier identifier

14. The role of COMT polymorphism in modulation of prefrontal activity during verbal fluency in bipolar disorder

Devrimci-Ozguven H., Alici Y. H., DEMİRBÜGEN ÖZ M., SÜZEN H. S., Kale H. E., Baskak B.
NEUROSCIENCE LETTERS , cilt.738, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

15. The relationship between plasma levels of clozapine and N-desmethyclozapine as well as M1 receptor polymorphism with cognitive functioning and associated cortical activity in schizophrenia

Kir Y., BASKAK B., Kusman A., Sayar-Akaslan D., Ozdemir F., Sedes-Baskak N., et al.
PSYCHIATRY RESEARCH-NEUROIMAGING , 2020 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

16. Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients

DEMİRBÜGEN ÖZ M., BASKAK B., UÇKUN Z., Artun N. Y., Ozdemir H., Ozel T. K., et al.
PHARMACOGENOMICS JOURNAL , cilt.20, sa.3, ss.443-450, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

17. Determination of Mirtazapine and Desmethyl Mirtazapine in Human Plasma by a New Validated HPLC Ultraviolet Method with a Simple and Reliable Extraction Method: Application to Therapeutic Drug Monitoring Study by 62 Real Patient Plasma

DURAL E., Baskak N. S., Ozcan H., Kir Y., BASKAK B., SÜZEN H. S.
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH , sa.1, ss.18-30, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

18. A Novel PCR-RFLP Method for Detection of POR*28 Polymorphism and its Genotype/Allele Frequencies in a Turkish Population

Ozdemir F., DEMİRBÜGEN ÖZ M., SÜZEN H. S.
CURRENT DRUG METABOLISM , cilt.20, sa.10, ss.845-851, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

19. The relationship between the serotonin 2A receptor gene-1438A/G and 102T/C polymorphisms and citalopram/sertraline-induced nausea in major depressed patients

DEMİRBÜGEN ÖZ M., UÇKUN Z., Yuce-Artun N., BASKAK B., Ozdemir H., Ozel T. K., et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL , cilt.33, sa.5, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

20. Genotype and Allele Frequency of CYP3A4-392A > G in Turkish Patients with Major Depressive Disorder

UÇKUN Z., BASKAK B., Ozdemir H., ÖZEL KIZIL E. T., ÖZGÜVEN H., SÜZEN H. S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.15, sa.2, ss.200-206, 2018 (ESCI, Scopus, TRDizin) identifier identifier identifier

21. Genotype and Allele Frequency of CYP3A4-392A G in Turkish patients with major depressive disorder CYP3A4-392A G and Major Depressive Disorder.

UÇKUN Z., BASKAK B., ÖZDEMİR REZAKİ H., ÖZEL KIZIL E. T., ÖZGÜVEN H., SÜZEN H. S.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.15, sa.2, ss.200-206, 2018 (Scopus)

22. A Genotyping and Phenotyping Study Concerning thePossible Effects of Some Inflammatory Cytokine GenePolymorphisms on the Development of Coal Workers’Pneumoconiosis

ATEŞ İ., KARAKAYA M. A., SÜZEN H. S., YÜCESOY B.
SOJ Immunology , cilt.5, sa.1, ss.1-5, 2017 (Hakemli Dergi) Sürdürülebilir Kalkınma

23. Possible effects of Paraoxonase 1 Q192R polymorphism on serum paraoxonase activities of a group of type 2 Diabetes Mellitus patients.

ATEŞ İ., ALTUNER D., SÜZEN H. S., Varan Koç G., KARAKAYA M. A.
Open Access Journal of Pharmaceutical Research , cilt.1, sa.4, ss.1-6, 2017 (Hakemli Dergi)

24. Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients

Yuce-Artun N., BASKAK B., ÖZEL KIZIL E. T., Ozdemir H., UÇKUN Z., ÖZGÜVEN H., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.38, sa.2, ss.388-394, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

25. Association between the 5-HTTLPR polymorphism and response to citalopram in Turkish patients with major depressive disorder Major Depresif Bozukluğu Olan Türk Hastalarda 5-HTTLPR Polimorfizmin ve Sitalopram Yanıtı Arasındaki İlişkisi

Uckun Z., BASKAK B., Ozdemir H., Ozelkizil E. T., Devrimci Ozguven H., SÜZEN H. S.
Turkish Journal of Pharmaceutical Sciences , cilt.13, sa.2, ss.145-158, 2016 (Scopus) identifier

26. Association Between the 5 HTTLPR Polymorphism and Response to Citalopram in Turkish Patients with Major Depressive Disorder

UÇKUN Z., BASKAK B., ÖZDEMİR REZAKİ H., ÖZEL KIZIL E. T., ÖZGÜVEN H., SÜZEN H. S.
Turkish Journal Of Biology , cilt.13, sa.2, ss.145-158, 2016 (SCI-Expanded)

27. The impact of CYP2C19 polymorphisms on citalopram metabolism in patients with major depressive disorder

Uckun Z., Baskak B., ÖZEL KIZIL E. T., Ozdemir H., ÖZGÜVEN H., SÜZEN H. S.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS , cilt.40, sa.6, ss.672-679, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

28. DETERMINATION OF SERTRALINE AND ITS METABOLITE BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY IN PLASMA

Yuce-Artun N., ÖZEL KIZIL E. T., BASKAK B., ÖZGÜVEN H., DUYDU Y., SÜZEN H. S.
REVUE ROUMAINE DE CHIMIE , cilt.60, sa.5-6, ss.543-548, 2015 (SCI-Expanded, Scopus) identifier identifier

29. Investigation of the Association between the CYP7A1 A 203C Polymorphism and Barrett s Esophagus in British Population

UÇKUN Z., McADAM L., SÜZEN H. S., JENKINS G.
JOURNAL OF APPLIED BIOLOGICAL SCIENCES , cilt.9, sa.1, ss.69-71, 2015 (Hakemli Dergi)

30. Evaluation of the Genotoxic Effects of Patients UndergoingHyperbaric Oxygen (HBO) Therapy

ÜSTÜNDAĞ A., ŞİMŞEK K., AY H., Dündar K., SÜZEN H. S., AYDIN A., et al.
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.11, sa.2, ss.203-208, 2014 (Scopus)

31. Allele and genotype frequencies of CYP2B6 in a Turkish population

Yuce-Artun N., Kose G., SÜZEN H. S.
MOLECULAR BIOLOGY REPORTS , cilt.41, sa.6, ss.3891-3896, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

32. Evaluation of the genotoxic effects of patients undergoing hyperbaric oxygen (HBO) therapy Hiperbarik oksijen tedavisinin (HBOT) sebep olduǧu genotoksik etkilerin İncelenmesi

ÜSTÜNDAĞ A., Şimşek K., Ay H., Dündar K., SÜZEN H. S., Aydin A., et al.
Turkish Journal of Pharmaceutical Sciences , cilt.11, sa.2, ss.203-208, 2014 (SCI-Expanded) identifier

33. Cytogenetic Damage in Turkish Coke Oven Workers Exposed to Polycyclic Aromatic Hydrocarbons: Association with CYP1A1, CYP1B1, EPHX1, GSTM1, GSTT1, and GSTP1 Gene Polymorphisms

ADA A. O., demiroğlu c., yılmazer m., SÜZEN H. S., Demirbağ A., Efe S., et al.
Arh Hig Rada Toksikol , cilt.64, sa.3, ss.359-369, 2013 (Hakemli Dergi)

34. CYTOGENETIC DAMAGE IN TURKISH COKE OVEN WORKERS EXPOSE l TO POLYCYCLIC AROMATIC HYDROCARBONS: ASSOCIATION WITH CYP1A1, CYP1B1, EPHX1, GSTM1, GSTT1, AND GSTP1 GENE POLYMORPHISMS

ADA A. O., Demiroglu C., Yilmazer M., SÜZEN H. S., Demirbag A. E., Efe S., et al.
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY , cilt.64, sa.3, ss.359-369, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

35. DNA integrity in patients undergoing hyperbaric oxygen (HBO) therapy

ÜSTÜNDAĞ A., Simsek K., Ay H., Dundar K., SÜZEN H. S., AYDIN A., et al.
TOXICOLOGY IN VITRO , cilt.26, sa.7, ss.1209-1215, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

36. The relationship of PON1 QR 192 and LM 55 polymorphisms with serum paraoxonase activities of Turkish diabetic patients

Altuner D., ATEŞ İ., SÜZEN H. S., Koc G. V., Aral Y., Karakaya A.
TOXICOLOGY AND INDUSTRIAL HEALTH , cilt.27, sa.10, ss.873-878, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

37. Are PON1 Q/R 192 and M/L 55 polymorphisms risk factors for diabetes complications in Turkish population?

Altuner D., SÜZEN H. S., ATEŞ İ., Koc G. V., Aral Y., Karakaya A.
CLINICAL BIOCHEMISTRY , cilt.44, sa.5-6, ss.372-376, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

38. Possible effect of gene polymorphisms on the release of TNF alpha and IL1 cytokines in coal workers' pneumoconiosis

ATEŞ İ., Yucesoy B., ATAK YÜCEL A., SÜZEN H. S., Karakas Y., Karakaya A.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY , cilt.63, sa.1-2, ss.175-179, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

39. CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients

Ada A. O., Kunak S. C., Hancer F., Bilgen S., SÜZEN H. S., Alpar S., et al.
NEOPLASMA , cilt.57, sa.6, ss.512-521, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

40. CAT C-262T and GPX1 Pro198Leu polymorphisms in a Turkish population

SÜZEN H. S., Gucyener E., Sakalli O., Uckun Z., Kose G., Ustel D., et al.
MOLECULAR BIOLOGY REPORTS , cilt.37, sa.1, ss.87-92, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

41. Quantitative determination of citalopram and its metabolite desmethycitalopram in plasma by high performance liquid chromatography

Uckun Z., SÜZEN H. S.
Fabad Journal of Pharmaceutical Sciences , cilt.34, sa.4, ss.195-201, 2009 (Scopus) identifier

42. Association of cytokine gene polymorphisms in CWP and its severity in Turkish coal workers

Ates İ., SÜZEN H. S., Yucesoy B., TEKİN İ. Ö., Karakaya A.
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE , cilt.51, sa.10, ss.741-747, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

43. The role of GSTM1 and GSTT1 polymorphisms in head and neck cancer risk

SÜZEN H. S., Guvenc G., Turanli M., Comert E., Duydu Y., ELHAN A. H.
ONCOLOGY RESEARCH , cilt.16, sa.9, ss.423-429, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

44. Polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1 in a male Turkish population

Ada A. O., SÜZEN H. S., Iscan M.
INTERNATIONAL JOURNAL OF TOXICOLOGY , cilt.26, sa.1, ss.41-46, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

45. Deoxycholic acid at neutral and acid pH, is genotoxic to oesophageal cells through the induction of ROS: the potential role of anti-oxidants in Barrett's oesophagus

Jenkins G. J. S., D'Souza F. R., SÜZEN H. S., Eltahir Z. S., James S. A., Parry J. M., et al.
CARCINOGENESIS , cilt.28, sa.1, ss.136-142, 2007 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

46. Cytokine genes in susceptibility to coal workers' pneumoconiosis

Karakaya A., Ates İ., Yucesoy B., SÜZEN H. S.
TOXICOLOGY LETTERS , cilt.164, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

47. Biological monitoring of environmental exposure to polycyclic aromatic hydrocarbons: 1-hydroxypyrene in urine of Turkish coke oven workers

Yilmazer M., Ada A., SÜZEN H. S., Demiroglu C., Demiroglu A., Efe S., et al.
BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY , cilt.76, sa.4, ss.559-565, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

48. TYMS and DPYD polymorphisms in a Turkish population

SÜZEN H. S., Yuce N., Guvenc G., Duydu Y., Erke T.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , cilt.61, sa.12, ss.881-885, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

49. Evaluation of increased proportion of cells with unusually high sister chromatid exchange counts as a cytogenetic biomarker for lead exposure

Duydu Y., Dur A., SÜZEN H. S.
BIOLOGICAL TRACE ELEMENT RESEARCH , cilt.104, sa.2, ss.121-129, 2005 (SCI-Expanded, Scopus) identifier identifier identifier

50. Molecular analysis of delta-aminolevulinic acid dehydratase (ALAD) gene polymorphism in a Turkish population

SÜZEN H. S., Duydu Y., Aydin A.
BIOCHEMICAL GENETICS , cilt.42, sa.11-12, ss.461-467, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

51. The oxidative DNA base damage in testes of rats after intraperitoneal cadmium injection

Ates İ., SÜZEN H. S., Aydin A., Karakaya A.
BIOMETALS , cilt.17, sa.4, ss.371-377, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

52. Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population

Ada A., SÜZEN H. S., Iscan M.
TOXICOLOGY LETTERS , cilt.151, sa.1, ss.311-315, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

53. Influence of delta-aminolevulinic acid dehydratase (ALAD) polymorphism on the frequency of sister chromatid exchange (SCE) and the number of high-frequency cells (HFCs) in lymphocytes from lead-exposed workers

Duydu Y., SÜZEN H. S.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS , cilt.540, sa.1, ss.79-88, 2003 (SCI-Expanded, Scopus) identifier identifier identifier identifier

54. Influence of the delta-aminolevulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in Turkish storage battery manufacturing workers

SÜZEN H. S., Duydu Y., Aydin A., Isimer A., Vural N.
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE , cilt.43, sa.2, ss.165-171, 2003 (SCI-Expanded, Scopus) identifier identifier identifier

55. Correlation between lead exposure indicators and sister chromatid exchange (SCE) frequencies in lymphocytes from inorganic lead exposed workers

Duydu Y., SÜZEN H. S., Aydin A., Cander O., Uysal H., Isimer A., et al.
ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY , cilt.41, sa.2, ss.241-246, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

56. The oxidative DNA base damage in testes tissue of rats after intraperitoneal cadmium injection

Karakaya A., Ates İ., Jaruga P., SÜZEN H. S., Dizdaroglu M.
TOXICOLOGY , cilt.164, sa.1-3, ss.58-59, 2001 (SCI-Expanded) identifier

57. Analysis of ras gene mutation in human oral tumours by polymerase chain reaction and direct sequencing

SÜZEN H. S., Parry J. M.
Turkish Journal of Medical Sciences , cilt.31, sa.3, ss.217-223, 2001 (SCI-Expanded) Sürdürülebilir Kalkınma identifier

58. Delta-aminolevulinic acid dehydratase (ALAD) genetic polymorphism in Turkish population

SÜZEN H. S.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.30, sa.1, ss.27-38, 2001 (Scopus) identifier

59. A genotypic mutation technique: Restriction site mutation method

SÜZEN H. S., Parry J.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.28, sa.2, ss.85-97, 1999 (Scopus) identifier

60. Restriction site mutation analysis in tobacco smoke exposed rats Sigara dumanina maruz birakilmis sicanlarda sinirli bolge mutasyon analizi

SÜZEN H. S., Parry J.
Acta Pharmaceutica Turcica , cilt.41, sa.4, ss.165-171, 1999 (Scopus) identifier

61. Simultaneous determination of guaiphenesin and codeine phosphate in tablets by high-performance liquid chromatography

SÜZEN H. S., Akay C., Cevheroglu S.
FARMACO , cilt.54, sa.10, ss.705-709, 1999 (SCI-Expanded, Scopus) identifier identifier

62. The restriction site mutation assay: a review of the methodology development and the current status of the technique

Jenkins G., SÜZEN H. S., Sueiro R., Parry J.
MUTAGENESIS , cilt.14, sa.5, ss.439-448, 1999 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

63. Validation of hippuric acid as a biomarker of toluene exposure

Duydu Y., SÜZEN H. S., Erdem N., Uysal H., Vural N.
BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY , cilt.63, sa.1, ss.1-8, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

64. Analysis of 7,12-dimethylbenz[a]anthracene induced mutations by the use of restriction site mutation technique in the rat

SÜZEN H. S., Parry J.
Fabad Journal of Pharmaceutical Sciences , cilt.24, sa.2, ss.67-73, 1999 (Scopus) identifier

65. The use of an internal standard molecule for determining mutation frequency in restriction site mutation method

Süzen H. S., Parry J.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.28, sa.1, ss.1-13, 1999 (Scopus) identifier

66. A modified method for determination of hippuric acid in urine by HPLC

DUYDU Y., SÜZEN H. S., VURAL N., ERDEM N., UYSAL H.
Ankara Universitesi Eczacilik Fakultesi Dergisi , cilt.28, sa.1, ss.37-46, 1999 (Scopus) identifier

67. Urinary excretion of total and inorganic lead in tetraethyllead exposed workers

Duydu Y., SÜZEN H. S., Aydin A., Sayal A., Isimer A., Vural N.
BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY , cilt.60, sa.3, ss.395-401, 1998 (SCI-Expanded, Scopus) identifier identifier identifier

68. Application of the restriction site mutation technique to N-methyl-N-nitrosourea-induced mutations in the rat

SÜZEN H. S., Jenkins G., Parry J.
TERATOGENESIS CARCINOGENESIS AND MUTAGENESIS , cilt.18, sa.4, ss.171-182, 1998 (SCI-Expanded, Scopus) identifier identifier identifier

69. EVALUATION OF THE BIOLOGICAL THRESHOLD VALUE OF URINARY CADMIUM CONCENTRATION IN A GROUP OF WORKERS

KARAKAYA A., SÜZEN H. S., VURAL N., OFLAZ G.
BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY , cilt.51, sa.4, ss.483-489, 1993 (SCI-Expanded, Scopus) identifier identifier identifier

70. ANALYSIS OF THE SERUM PARAOXONASE ARYLESTERASE POLYMORPHISM IN A TURKISH POPULATION

KARAKAYA A., SÜZEN H. S., SARDAS S., KARAKAYA A., VURAL N.
PHARMACOGENETICS , cilt.1, sa.1, ss.58-61, 1991 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 53

1. Quantification of Naltrexone and 6β-Naltrexol in Human Plasma for Monitoring Alcohol Use Disorder Treatment

Bozmaoğlu C. H., Tok K. C., Danışman M., Süzen H. S., Gümüştaş M.
31st International Symposium on Electro- and Liquid-Phase Separation Techniques (ITP 2025), Ankara, Türkiye, 24 - 27 Ağustos 2025, (Özet Bildiri)

2. Targeted HPLC Approach for Diazepam Plasma Detection in Alcohol Withdrawal Syndrome Patients

Tok K. C., Özkan Kotiloğlu S., Bozmaoğlu C. H., Danışman M., İlhan İ., Akyüzlü D., et al.
13th Annual Symposium on Physical and Analytical Chemistry (ASPAC 2024), Tbilisi, Gürcistan, 20 - 22 Aralık 2024, (Tam Metin Bildiri)

3. Development of A Headspace GC-FID Method for the Analysis of Alcohol-Based Hand Sanitizers

Tosunoğlu E., Avcı K., Tok K. C., Sevim B., Güneş Altuntaş E., Süzen H. S., et al.
13th Annual Symposium on Physical and Analytical Chemistry (ASPAC 2024), Tbilisi, Gürcistan, 20 - 22 Aralık 2024, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

4. Assessment of Genetic and Lifestyle Factors on Clozapine and N-desmethylclozapine Plasma Levels in Schizophrenia Patients

Demirbügen Öz M., Özdemir F., Tok K. C., Dural E., Kır Y., Ulusoy M., et al.
XVth Symposium of the Task Force Therapeutic Drug Monitoring of the AGNP, Freiburg, Almanya, 20 - 22 Mart 2024, ss.87, (Özet Bildiri) Sürdürülebilir Kalkınma

5. Extraction Strategies for Simultaneous Determination of the Buprenorphine/Naloxone Combination from Plasma Samples

Bozmaoğlu C. H., Başarır E. P., Tok K. C., Danışman M., Süzen H. S., Gümüştaş M.
12th Annual Symposium on Physical and Analytical Chemistry (ASPAC 2023), Tbilisi, Gürcistan, 15 - 17 Aralık 2023, (Özet Bildiri)

6. Sample Preparation and Analysis with the Spotlight on Forensically and Clinically Important Drugs

Gümüştaş M., Bozmaoğlu C. H., Tok K. C., Süzen H. S.
12th Annual Symposium on Physical and Analytical Chemistry (ASPAC 2023), Tbilisi, Gürcistan, 15 - 17 Aralık 2023, (Özet Bildiri)

7. Therapeutic Drug Monitoring: A Bioanalytical Method for Naltrexone and Major Metabolite

GÜMÜŞTAŞ M., BOZMAOĞLU C. H., TOK K. C., SÜZEN H. S., DANIŞMAN M.
60th annual meeting of the International Association of Forensic Toxicologists (TIAFT 2023), ROMA, İtalya, 27 - 31 Ağustos 2023, (Özet Bildiri)

8. Evaluation of Dilute-and-Shoot and Liquid-Phase Extraction Methods for the Analysis of Buprenorphine/Naloxone Combination Used in the Treatment of Opioid Addiction

BOZMAOĞLU C. H., BAŞARIR E. P., TOK K. C., SÜZEN H. S., GÜMÜŞTAŞ M.
60th annual meeting of the International Association of Forensic Toxicologists (TIAFT 2023), ROMA, İtalya, 27 - 31 Ağustos 2023, (Özet Bildiri)

9. Analytical Method Development and Validation of Pregabalin and Gabapentin in Pharmaceutical, Biological, and Environmental Samples Using HPLC

TOK K. C., BOZMAOĞLU C. H., SÜZEN H. S., GÜMÜŞTAŞ M.
60th annual meeting of the International Association of Forensic Toxicologists (TIAFT 2023), ROMA, İtalya, 27 - 31 Ağustos 2023, (Özet Bildiri)

10. LC-MS/MS-Based Quantitative Analysis of A Tricyclic Antidepressant and Its Major Metabolite

BOZKURT N. N., TOK K. C., BOZMAOĞLU C. H., YALÇINKAYA B., BASKAK B., GÜMÜŞTAŞ M., et al.
33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA2023), Ankara, Türkiye, 02 Temmuz 2023, (Özet Bildiri)

11. Accurate and Precise Determination of Pregabalin in Pharmaceutical Formulations using HPLC-UV Methodology

TOK K. C., BOZMAOGLU C. H., SÜZEN H. S., GÜMÜŞTAŞ M.
33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA2023), Ankara, Türkiye, 02 Temmuz 2023, (Özet Bildiri)

12. The Effect of Pharmacokinetic Genes Polymorphisms to the Plasma Clozapine and Norclozapine Levels in Patients with Schizophrenia

ÖZDEMİR F., TOK K. C., DURAL E., GÜMÜŞTAŞ M., BASKAK B., SÜZEN H. S.
33rd International Symposium on Pharmaceutical and Biomedical Analysis (PBA2023), Ankara, Türkiye, 02 Temmuz 2023, (Özet Bildiri)

13. New Perspectives for the Extraction of Naltrexone and its Metabolite Used in the Treatment of Opioid Use Disorder

Bozmaoğlu H. C., Tok K. C., Gümüştaş M., Süzen H. S.
2nd European Sample Preparation e-Conference (EuSP2022), 14 - 16 Mart 2022, ss.1, (Özet Bildiri)

14. THE IMPACT OF THE CYTOCHROME P450 3A4 (CYP3A4*22) POLYMORPHISM ON TACROLIMUS DOSE REQUIREMENTS AND EXPOSURE DURING EARLY PERIOD FOLLOWING KIDNEY TRANSPLANTATION

DEMİRBÜGEN ÖZ M., KEVEN K., SÜZEN H. S.
13th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Türkiye, 22 - 25 Haziran 2021, (Özet Bildiri)

15. Development of HPLC Method for the Determination of Opioid Antagonist Used in the Treatment of Opioid Disorder

BOZMAOGLU C. H., TOK K. C., TEKTAŞ S., SERİM T. M., YÜKSEL N., ÖZDEMİR A. N., et al.
3rd International Gazi Pharma Symposium Series (GPSS2021), Türkiye, 08 Eylül 2021, (Özet Bildiri)

16. THE IMPORTANCE OF THE CYTOCHROME P450 3A5 (CYP3A5*3) POLYMORPHISM ON TACROLIMUS DOSE REQUIREMENTS AND TROUGH LEVELS DURING EARLY PERIOD AFTER KIDNEY TRANSPLANTATION

DEMİRBÜGEN ÖZ M., KEVEN K., SÜZEN H. S.
2nd INTERNATIONAL CONGRESS OF MULTIDISCIPLINARY STUDIES IN MEDICAL SCIENCES, Ankara, Türkiye, 13 - 14 Şubat 2021, (Özet Bildiri)

17. The Effect of Enantiomer Elution Order on Determination of Minor Enantiomeric Impurity: The Case of Ketoprofen

TOK K. C., GÜMÜŞTAŞ M., SÜZEN H. S., ÖZKAN S. A., FARKAS T., CHANKVETADZE B.
2nd International Congress onAnalytical and Bioanalytical Chemistry (2nd ICABC 2020) Antalya/Türkiye, Antalya, Türkiye, 11 - 14 Mart 2020, (Tam Metin Bildiri)

18. Adli veteriner toksikoloji yönüyle hayvan istismarı

YURDAKÖK DİKMEN B., SÜZEN H. S.
I. International VI. Veterinary Pharmacology and Toxicology Congress., Kayseri, Türkiye, 4 - 07 Eylül 2019, ss.254-264, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

19. Efficient Extraction Method for Simultaneous Determination of Bisphenols and Phthalates in Meconium Specimens Using GC-MS

Tok K. C., Gümüştaş M., Mohamed K. M., Arsan S., Gürbüz A., Süzen H. S.
EUROANALYSIS XX, İstanbul, Türkiye, 1 - 05 Eylül 2019, ss.1, (Özet Bildiri) Sürdürülebilir Kalkınma

20. The role of genetic and epigenetic factors in major depressive disorder

DEMİRBÜGEN ÖZ M., SÜZEN H. S.
5th International Congress onEpigenetics Chromatin, Viyana, Avusturya, 22 - 23 Ağustos 2019, (Özet Bildiri)

21. 5-HT2A rs6311 and rs6313 Polymorphisms With Obsessive-Compulsive Symptoms in Schizophrenia Patients Under Clozapine Monotherapy.

KIR Y., BASKAK B., KUŞMAN A., SAYAR AKASLAN D., SEDES BASKAK N., BARAN Z., et al.
11th International Congress of Psychopharmacology, Antalya, Türkiye, 18 - 21 Nisan 2019, (Tam Metin Bildiri)

22. Relationship of clozapine plasma level, 5-HT2A rs6311 and rs6313 polymorphisms with obsessive-compulsive symptoms in schizophrenia patients under clozapine monotherapy

KIR Y., BASKAK B., KUŞMAN A., SAYAR AKASLAN D., SEDES BASKAK N., BARAN Z., et al.
11th International Congress on Psychopharmacology, Antalya, Türkiye, 18 - 21 Nisan 2019, cilt.29, ss.100-101, (Özet Bildiri)

23. Rapid Determination of Clozapine and Main Metabolite by HighPerformance Liquid Chromatography

TOK K. C., ÖZDEMİR F., GÜMÜŞTAŞ M., SÜZEN H. S.
1st INTERNATIONAL CONGRESS on ANALYTICAL and BIOANALYTICAL CHEMISTRY, Antalya, Türkiye, 27 - 30 Mart 2019, (Tam Metin Bildiri)

24. The Role of Comt Polymorphisms in Modulation of Prefrontal Activity During Verbal Fluency in Bipolar Disorder

HOŞGÖREN Y., DEVRİMCİ ÖZGÜVEN H., BASKAK B., DEMİRBÜGEN ÖZ M., SÜZEN H. S., DUMAN B.
Bipolar Bozukluklar Derneği Bipolar Bozukluk Araştırmacı Klinisyen Eğitim Toplantısı (BAKET), Türkiye, 15 - 16 Eylül 2018, (Özet Bildiri)

25. THE POSSSIBLE ASSOCIATION BETWEEN BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) GENETIC POLYMORPHISM VAL66MET AND SUSCEPTIBILITY TO BIPOLAR DISORDERS (BPD)

DEMİRBÜGEN ÖZ M., HOŞGÖREN Y., DUMAN B., BASKAK B., DEVRİMCİ ÖZGÜVEN H., SÜZEN H. S.
12th International Symposium on Pharmaceutical Sciences (ISOPS-12), 26 - 29 Haziran 2018, (Özet Bildiri)

26. THE 5-HYDROXYTRIPTAMINE 2A RECEPTOR -1438A/G AND 102T/C POLIMORPHISMS AND NAUSEA SIDE EFFECT IN CITALOPRAM TREATED MAJOR DEPRESSIVE DISORDER PATIENTS

DEMİRBÜGEN ÖZ M., UÇKUN Z., YÜCE ARTUN N., DEVRİMCİ ÖZGÜVEN H., SÜZEN H. S.
12th International Symposium on Pharmaceutical Sciences, 26 - 29 Haziran 2018, (Özet Bildiri)

27. COMMON GENE POLYMORPHISMS IN ANTIOXIDANT ENZYME SYSTEMS AND ITS RELATION WITH THE NUTRION

DEMİRBÜGEN M., SÜZEN H. S.
1st International Food and Medicine Congress, 24 - 27 Mayıs 2018, (Özet Bildiri)

28. THE RELATIONSHIP BETWEEN THE DIFFERENT GENETIC POLYMORPHISMS AND METHYLPHENIDATE INDUCED ADVERSE DRUG REACTIONS IN ATTENTION DEFICIT HYPERACTIVITY DISORDER PATIENTS

DEMİRBÜGEN M., SÜZEN H. S.
1st International Food and Medicine Congress, 24 - 27 Mayıs 2018, (Özet Bildiri)

29. Kidney, breast and stomach cancers in relation to internal concentrations of persistent organic pollutants, DNA damage markers and related polymorphisms

ORHAN H., SÜZEN H. S., KOCAGÖZ R., ONAT İ., DEMİRBÜGEN ÖZ M., TURNA B., et al.
The 10th Congress of the Toxicology in Developing Countries (CTDC10th), 17 - 22 Nisan 2018, cilt.4, ss.18, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

30. Quantitative Determination of Mirtazapine and Its Major Metabolite in Plasma by a Developed and Validated HPLC-UV Method

DURAL E., Özcan H., SÜZEN H. S.
1st International Symposium on Multidisciplinary Studies and Innovative Technologies, Tokat, Türkiye, 2 - 04 Kasım 2017, (Özet Bildiri)

31. The effects of some cytokİne gene polymorphİsms on type 2 diabetes and its complications.

ATEŞ İ., ALTUNER D., SÜZEN H. S., KARAKAYA M. A.
2nd International Gazi Pharma Symposium Series, 11 - 13 Ekim 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

32. The Serotonin 2A Receptor Gene -1438A/G Polymorphism and Sertraline Induced Nausea in Major Depressed Turkish Patients

DEMİRBÜGEN M., UÇKUN Z., SÜZEN H. S.
2nd International Gazi Pharma Symposium Series(GPSS-2017), Ankara, Türkiye, 11 - 13 Ekim 2017, (Özet Bildiri)

33. DETERMINATION OF MIRTAZAPINE AND DESMETHYL MIRTAZAPINE IN PLASMA BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY ULTRAVIOLET DETECTION

DURAL E., ÖZCAN H., SÜZEN H. S.
2nd International Gazi PharmaSymposium Series (GPSS-2017), 11 - 13 Ekim 2017, (Özet Bildiri)

34. Plazma Sitalopram ve Metaboliti Desmetilsitalopramın Major Depresif Hastalarda HPLC ile Tayini

SÜZEN H. S., UÇKUN Z., ÖZGÜVEN H.
17.Krmatografi Kongresi, Türkiye, 20 - 22 Eylül 2017, (Özet Bildiri)

35. Plazma sitalopram ve metaboliti desmetilsitalopramın majör depresif hastalarda HPLC ile tayini

SÜZEN H. S., UÇKUN Z., ÖZGÜVEN H.
17. Kromatografi Kongresi, Çorum, Türkiye, 20 - 22 Eylül 2017, (Özet Bildiri)

36. Sitalopram kullanan major depresyon hastalarında bulantı/kusma advers etkisinin serotonin-2A reseptör geni -1438A/G polimorfizmi ile ilişkisinin incelenmesi

DEMİRBÜGEN M., SÜZEN H. S.
1. Anadolu Üniversitesi Eczacılık Fakültesi Sempozyumu, Türkiye, 1 - 02 Haziran 2017, (Özet Bildiri)

37. The role of some cytokine gene polymorphisms on Type 2 diabetes

ATEŞ İ., SÜZEN H. S., KARAKAYA M. A.
3. Uluslararası İlaç ve Eczacılık Kongresi (İVEK), 26 - 29 Nisan 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

38. Antipsychotic Drugs and the Risk of Sudden Cardiac Death

DEMİRBÜGEN M., SÜZEN H. S.
The 2nd International Congress and Workshop of Forensic Toxicology, 26 - 30 Mayıs 2016

39. The Potential Role of CYP2D6 Pharmacogenetics on Codeine Toxicity

UÇKUN Z., SÜZEN H. S.
The 2nd International Congress and Workshop of Forensic Toxicology, 26 - 30 Mayıs 2016

40. Pharmacogenetics Role in Forensic Toxicology

SÜZEN H. S.
The 2nd International Congress and Workshop of Forensic Toxicology, 26 - 30 Mayıs 2016

41. Determination of Sildenafil in Adulterated Herbal Supplements by HPLC UV

DURAL E., SÜZEN H. S., SÖYLEMEZOĞLU T.
The 2nd International Congress and Workshop of Forensic Toxicology, 26 - 30 Mayıs 2016

42. Comparisons of Mirtazapine Determination Methods with High Performance Liquid Chromatography

DURAL E., Özcan H., SÜZEN H. S.
The 2nd International Congress and Workshop of Forensic Toxicology, 26 - 30 Mayıs 2016

43. The impact of genetic differences on SSRIs metabolism in depressed patients

SÜZEN H. S., UÇKUN Z., YUCEARTUN N., BASKAK B., ÖZEL KIZIL E. T., ÖZDEMİR REZAKİ H., et al.
Turk Heltox Toxicology Congress, 21 - 24 Ekim 2015, (Özet Bildiri)

44. 5 HT2A receptor 102T C polymorphism and incidence of nausea induced by sertraline treatment

DEMİRBÜGEN M., UÇKUN Z., YÜCE N., BASKAK B., SÜZEN H. S.
Turk Heltox Toxicology Congress, 21 - 24 Ekim 2015

45. Molecular Analysis of CYP2B6 Gene A785G Polymorphism in a Turkish Population

SÜZEN H. S., YUCEARTUN N.
3rd ESPT Conference, 7 - 10 Ekim 2015, cilt.30

46. THE ASSOCIATION OF SEROTONINE 2A RECEPTOR 102 T/C POLYMORPHISM AND NAUSEA IN CITALOPRAM TREATED PATIENTS

DEMİRBÜGEN M., BASKAK B., Devrimci Özgüven H., Kızıl Özel T., SÜZEN H. S.
11th İnternational Symposium on Pharmaceutical Sciences, 9 - 12 Haziran 2015, (Özet Bildiri)

47. The association of serotonin 2A receptor 102T C polymorphism and nausea in citalopram treated patients

DEMİRBÜGEN M., BASKAK B., ÖZEL KIZIL E. T., ÖZGÜVEN H., SÜZEN H. S.
11th Internetional Symposium on Pharmaceutical Sciences, 9 - 12 Haziran 2015

48. Correlation between some cytokine gene polymorphisms and susceptibility to type 2 diabetes

ATEŞ İ., ALTUNER D., SÜZEN H. S., KARAKAYA M. A.
11th Internetional Symposium on Pharmaceutical Sciences, 9 - 12 Haziran 2015 Sürdürülebilir Kalkınma

49. CYP2C19 17 Polymorphism and Major Depression Patients Treated with Citalopram

UÇKUN Z., BASKAK B., ÖZDEMİR REZAKİ H., ÖZEL KIZIL E. T., ÖZGÜVEN H., SÜZEN H. S.
11th Internetional Symposium on Pharmaceutical Sciences, 9 - 12 Haziran 2015

50. The impact of xenobiotic metabolizing enzyme polymorphisms on cytogenetic biomarkers in Turkish coke oven workers exposed to polycyclic aromatic hydrocarbons

Iscan M., Ada A. O., Demiroglu C., Yilmazer M., SÜZEN H. S., Demirbag A. E., et al.
49th Congress of the European-Societies-of-Toxicology (EUROTOX), Interlaken, İsviçre, 1 - 04 Eylül 2013, cilt.221, (Özet Bildiri) identifier

51. THE ROLE OF CYP2C19 POLYMORPHISM IN MAJOR DEPRESSION PATIENTS TREATED WITH CITALOPRAM

Uckun Z., BASKAK B., ÖZEL KIZIL E. T., ÖZGÜVEN H., SÜZEN H. S.
14th Biennial Meeting of the European-Behavioural-Pharmacology-Society, Amsterdam, Hollanda, 26 - 29 Ağustos 2011, cilt.22, (Özet Bildiri) identifier

52. The role of CYP1A1 (Ile462Val) and CYP1B1 (Asn453Ser) polymorphisms in response to chemotherapy and survival in lung cancer patients

ADA A. O., Bilgen S., KUNAK C. S., Hancer F., SÜZEN H. S., Alpar S., et al.
46th Congress of the European-Societies-of-Toxicology, Dresden, Almanya, 13 - 16 Eylül 2009, cilt.189, (Özet Bildiri) identifier

53. Influences of genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 on the baseline level of micronuclei in human lymphocytes

Burgaz S., Ada A., Demiroglu C., Yilmazer-Musa M., SÜZEN H. S., Alemdar Y., et al.
10th International Congress of Toxicology, Tampere, Finlandiya, 11 - 15 Temmuz 2004, cilt.197, ss.254, (Özet Bildiri) identifier
Kitaplar 5

1. Major Depresyonda Bireyselleştirilmiş Tedavi ve Farmakogenetiğin Önemi

DEMİRBÜGEN ÖZ M., SÜZEN H. S.
Eczacılıkta Yenilikler 3, Özçelikay Gülbin, Yıldız İlkay, Editör, Ankara Üniversitesi Yayınları, Ankara, ss.447-456, 2020

2. Türk Farmakopesi-II Monograflar

ÖZKAN Y., İŞCAN G. S., SARAÇ TARHAN S., ÖZKAN S. A., AYDIN A., SÜZEN H. S., et al.
Anıl Reklam Matbaa LTD.STİ., 2017

3. Casarett And Doull’s Toksikolojinin Temelleri

SÜZEN H. S., ERKEKOĞLU Ü. P., ADA A. O., ERDEM O., ÇAKMAK G., demirel b.
Nobel, Ankara, 2017

4. TÜRK FARMAKOPESl-ll MONOGRAFLAR (Avrupa Farmakopesi Adaptasyonu) - 2016

ÖZKAN Y., SALTAN H. G., SARAÇ TARHAN S., ÖZKAN S. A., AYDIN A., SÜZEN H. S., et al.
T.C. Sağlık Bakanlığı Türkiya ilaç veTıbbl Cihaz. Kurumu, Ankara, 2016

5. Türk Farmakopesi II Monograflar Avrupa Farmakopesi Adaptasyonu 2016

SAVAŞER A., HASÇİÇEK C., ÖZKAN S. A., ÖZKAN Y., besikci a., Tas c., et al.
Anıl Reklam Matbaaa ltd., 2016
Metrikler

Yayın

155

Yayın (WoS)

64

Yayın (Scopus)

71

Atıf (WoS)

765

H-İndeks (WoS)

17

Atıf (Scopus)

794

H-İndeks (Scopus)

17

Atıf (Scholar)

330

H-İndeks (Scholar)

8

Proje

17

Tez Danışmanlığı

7

Açık Erişim

7
BM Sürdürülebilir Kalkınma Amaçları